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Aim: This paper describes our experience of 20 cases identiﬁed in the FEA vacuum core
biopsy.
Background: Screening mammography has contributed to the increased recognition of early
cancer, premalignant and preinvasive breast lesions. A premalignant lesion called FEA (ﬂat
epithelial atypia), although rarely recognized as the only lesion in the core biopsy, is a major
challenge in clinical proceedings. Increasing recognition is associated with an increasing
use  of the vacuum core biopsy as a tool for verifying nonpalpable lesions identiﬁed by
mammography, and suspected of being breast cancer.
Materials and methods: Of 4326 mammotome biopsies performed at our institution in
2000–2006, FEA was diagnosed in 20 patients (0.46%). These patients underwent surgery for
reexcsion. Data were collected for clinical, radiological and pathological ﬁndings to assess
factors associated with the underestimation of invasive lesions.
Results: Among 20 patients with FEA diagnosis, the mean age was 59.6, range 52–71. When
compared to the ADH group (mean age 55.45), the FEA patients were found to be statisti-
cally  signiﬁcantly older (p = 0.0002). Two patients 2/20 (10%) showed underestimation, with
invasive cancer on the ﬁnal pathology were G1 tubular cancer T1b, and G2 lobular cancer
T1a.
Conclusion: Although FEA is rarely diagnosed as the only lesion in a core biopsy, the ever
more common use of this diagnostic technique forces us to establish a clear clinical practice.The  problem is the underestimation of invasive lesions in the case of primary diagnosis of
FEA.  It seems that some percent of these cases can be identiﬁed by certain radiological or
pathological features, thus helping implement appropriate clinical management.
©  2011 Greater Poland Cancer Centre, Poland. Published by Elsevier Urban & Partner Sp.
phologically recognizable neoplastic lesion in the breast. It.  Backgroundn 1979, Azzopardi described intraepithelial neoplasia which
e called “clinging carcinoma in situ”.1 She regarded the lesion
s a variant of DCIS (ductal carcinoma in situ), which is easy
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to overlook in histopathology, and is due to cellular rather
than architectural changes. Currently, FEA is the earliest, mor-48 618850600; fax: +48 618850601.
is characterized by medium to large cellular atypia epithelial
single layer of cells. The degree of cellular atypia should be
a determinant of the division of FEA into 2 groups – a high
. Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved.
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(pleomorphic variant) and a low degree of atypia (monomor-
phic variant). Azzopardi suggested new type of DCIS as 1, 2
or more  layers of atypical cell lines without the presence of
intraepithelial proliferation. It differs from the CCC (colum-
nar cell changes) in the presence of cellular atypia, and from
the ADH (atypical ductal hyperplasia) in the existence of
a comprehensive architectural atypia. Over the years, the
importance of recognizing clinging DCIS has been a matter
of discussion. Only results of molecular level research showed
the association between this early neoplastic change and inva-
sive breast cancer.2 A link was also shown between lobular
and tubular cancer and changes in the type of clinging. In
the course of years, many  different terms have been used
to describe the lesion. At present, two names are used – ﬂat
epithelial atypia, or ﬂat DIN (ductal intraepithelial neopla-
sia) – DIN1 (in accordance with the guidelines of the WHO
classiﬁcation of 2003).3 Patients who are diagnosed with FEA
are just a few years younger than the group with ADH (an
average of 44–51 years versus an average of 54 years in the
case of ADH).4–8 The most common radiographic presence of
FEA are microcalciﬁcations.9 They occur in approximately 74%
of patients with FEA.10 Observed ultrasound, they present a
poorly demarcated nodular mass with irregular shape, some-
times with arched or spicular border.9 The aim of this study
is to evaluate the underestimation of invasive lesions after
the initial diagnosis of FEA in mammotome  vacuum core
biopsy.
2.  Materials  and  methods
Retrospectively analyzed 20 patients with a primary diagnosis
of FEA on the basis of mammotome  vacuum assisted 11 gauge
core needle biopsies. A biopsy was performed in the mamm-
tome biopsy outpatient clinic in the Department of Surgical
Oncology and General Surgery, Wielkopolska Cancer Centre.
For six and a half years, 4326 biopsies were done. Biopsies
were performed in patients with nonpalpable breast lesions.
In other cases, ultrasound-guided core needle biopsies were
performed (this group of patients is not the subject of the
present study). Mammotome  biopsy was performed on the
table, where patients were turned to face downwards (Fisher
Imaging, Denver, CO, USA) using 11 gauge directional vacuum
assisted biopsy systems (Mammotome Biopsy/Ethicon Endo-
Surgery, Cinncinatti, OH). They obtained an average of 12 cores
(from 7 to 30). Biopsies were performed by three oncological
surgeons. In most cases, patients were referred with a suspi-
cious mammogram image  detected in a nationwide screening
program. Patients with diagnosis of FEA were treated surgi-
cally by excision of the area where FEA was diagnosed. In the
case of ﬁnding the cancer re-excision if no clear margins were
found was performed together with sentinel node biopsy for
axillary nodal staging. For all cases, pictures and descriptions
of mammography, or ultrasound data were collected for review
(Figs. 1 and 2). The patients were re-examined and veriﬁed for
clinical data such as age, oncological history, family burden,
mammography, concomitant benign lesions of the breast, type
of operation.diotherapy 1 7 ( 2 0 1 2 ) 93–96
3.  Results
Among 20 patients with FEA diagnosis a mean age was 59.6,
ranging from 52 to 71. When compared to the ADH group
(mean age 55.45), the FEA patients are found to be statisti-
cally signiﬁcantly older (p = 0.0002). The two patients showed
underestimation 2/20 (10%) with invasive cancer on ﬁnal
pathology. Two patients with invasive cancer on the ﬁnal
pathology were G1 tubular invasive cancer T1b, and G2 lob-
ular invasive cancer T1a. After lymph node sampling, only the
lobular cancer patient showed lymph node metastasis in one
node. Radiological features showed tumor mass in 7 patients,
density in 2 patients, and microcalciﬁcations in 11 patients.
Underestimated patients had tumor mass and density. From
the pathological point of view, concomitant benign features
were observed: adenosis sclerosans in 4 patients, ﬁbrosis in 1
patient, mastopathia ﬁbrosa in 8 patients, mastopatia cystica
in 5 patients, adenosis microglandularis in 3 patients. Under-
estimated patients did not show concomitant pathological
features.
4.  Discussion
Discovering suspected microcalciﬁcations detected at screen-
ing mammography leads to diagnosis by stereotactic core nee-
dle biopsy. Currently, we can use stereotactic or ultrasound-
guided core needle biopsy for many  different breast
lesions.10,11 In case of the FEA, cancerous lesions of the breast
should be searched. In addition to problems related to the very
procedure of biopsy, destruction of specimens and a small
amount of tissue collected at biopsy, we must also handle
with its twisting, or crushing. All this makes it difﬁcult to
adequately assess results of histopathological examination.
Owing to the use of thicker biopsy needles (11 G instead of
14 G), greater number of biopsy fragments retrieved, and the
routine use of radiographs of collected tissue fragments, the
accuracy of microscopic examination has improved. There
are still no clear guidelines for the diagnosis of FEA in the
stereotactic biopsy. In only a few studies in small numbers of
patients lesions of invasive and preinvasive pattern occurred
in 13–30% of cases.8,12–17 DCIS and LN (lobular neoplasia) were
present along with FEA in 22–36% of cases.18 In the study
by Guerra-Wallace et al. describing the frequency of coexis-
tence of tumor diagnosis in the case of intraductal hyperplasia
(Columnare cell lesions) on the basis of core biopsy, the ﬁnal
excision was followed by a higher incidence of tumor in the
group with atypia (FEA-11/60–18%) compared to patients with-
out atypia – (UDH 10/135–7%).14 The report by Bonnet et al.,
nine cases with FEA were found in 167 biopsies. Of these
patients, two were detected to have DCIS, and three ADH (atyp-
ical ductal hyperplasia) after radical surgery.12 In the paper by
Kunju and Kleer, out of 14 patients diagnosed with FEA in core
biopsy (14 G), after surgical excision of the lesion, one was
found to show concomitant DCIS, and in two  cases invasive
cancers were detected.8 Underestimation of invasive lesions
amounted to 21%. It should also be noted that in other ﬁve
cases (36%) ADH was found, and LN and in one case (8%).
Usability testing of Ki-67 has been demonstrated as negative,
because regardless of whether additional clusters were found
reports of practical oncology and radiotherapy 1 7 ( 2 0 1 2 ) 93–96 95
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ancerous or not, the results were similar.15 It is important to
emonstrate the presence of chronic inﬂammation (29%) and
tromal changes (36%), such as myxoid changes and periductal
brosis, which are associated with FEA. The study by Piubello
t al. reported 875 patients who underwent core biopsy (11 G).
3 cases were diagnosed with FEA.17 None of these patients
howed concomitant cancer after surgical excision. However,
n the case of coexistent FEA and ADH found in 11 patients,
nderestimation of cancer was 30%. In the study by Chivukula
t al. on a group of 35 patients diagnosed with FEA, under-
stimation of the tumor was 14%, while in the presence of
EA together with ADH underestimation was 16.3%.13 There
as no statistical signiﬁcance between the underestimation
f cancer in the group with FEA, FEA + ADH and ADH alone.13
n the study by Lim et al. on ﬁve patients with CCL and atypia,
n one (20%) DCIS lesion were found after surgical excision.19
Fig. 2 – Tumor mass befoicrocalciﬁcations before and after biopsy.
Labbe-DeVilliers et al. described two subgroups of patients:
CCH with atypia – 25 cases, CCC with atypia – 15 patients.20
Invasive lesions were diagnosed in 4 patients (10%), and DCIS
in 3 (8%), accounting for a total underestimation of the tumor
of 18%. All tumors were found in the group of CCH with atypia.
If the CCC with atypia in mammography images outbreak was
less than 10 mm,  there was no concomitant cancer changes.
In the study by de Mascarel et al. on the basis of 2833 biop-
sies due to suspected microcalciﬁcations, FEA was found in
101 patients.21 Underestimation of the tumor occurred in 17
of them (17%). Among the concomitant cancers were 12 cases
of DCIS or invasive ductal cancer, four cases of tubular cancer
and one of lobular carcinoma. In our study, FEA was diagnosed
in 20 patients, representing 0.5% of all cases diagnosed in the
mammotome  biopsy. Studies with a percent of underestima-
tion in the case of FEA diagnosis are summarized in Table 1.
re and after biopsy.
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Table 1 – Underestimation of a cancer in case of FEA
diagnosis.
Study Number of
patients with
FEA
Underestimation
of a cancer
Guerra-Wallace et al. 60 11 (18%)
Bonnet et al. 9 2 (22%)
Kunju and Kleer 14 3  (21%)
Piubello et al. 33 0
Chivukula et al. 35 5 (14%)
Lim et al. 5 1 (20%)
r
1
1
1
1
1
1
1
1
1
1
2
2Labbe-DeVilliers et al. 40 7 (18%)
Mascarel et al. 101 17 (17%)
Current study 20 2 (10%)
Underestimation of invasive lesions occurred in two patients
(10%), both diagnosed with invasive cancer. There was a sig-
niﬁcant difference in age between the group of patients with
the diagnosis of FEA and a group with a diagnosis of ADH,
where the average age in the FEA group was 59.6 years and
versus 55.45 years in the ADH group. It is in opposition to
other results where patients with more  advanced pathological
ﬁndings, like ADH, are statistically older than FEA patients.4–8
The reason for this ﬁnding in our population is unclear, but
probably can be accounted for by a small number of patients
diagnosed with FEA. The question of eligibility of patients for
radical removal of the lesion remains unresolved. Does the
complete removal of microcalciﬁcations due to core biopsy
eliminate the need for surgical resection of the area? Will
greater amount of tissue collected during biopsy allow for
close observation of patients, instead of surgery? According to
Ho et al., even total resection of an area of microcalciﬁcations
in the case of ADH is associated with a 17% underestima-
tion of invasive cancer.7 In the case of FEA, the risk may
be the same. Magnetic resonance might be a useful tool in
diagnosis of premalignant lesions. But additional research is
required on the usefulness of this test. We  should also con-
sider better information for the patient as well as support,
especially in the case of increased risk of breast, cancer in the
future.22
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